Background -Cardiovascular diseases remain the predominant cause of death worldwide, with the prevalence of heart failure continuing to increase. Despite increased knowledge of the metabolic alterations that occur in heart failure, novel therapies to treat the observed metabolic disturbances are still lacking. Methods -Mice were subjected to pressure overload by means of angiotensin-II infusion or transversal aortic constriction (TAC). MicroRNA-146a was either genetically or pharmacologically knocked out, or genetically overexpressed in cardiomyocytes. Furthermore, overexpression of dihydrolipoyl succinyltransferase (DLST) in the murine heart was performed by means of an adeno-associated virus (AAV9). Results -MicroRNA-146a was up-regulated...
Cardiac hypertrophy is a frequent pathological reaction to hypertension, pulmonary hypertension, and...
Expression of microRNA-652 (miR-652) increases in the diseased heart, decreases in a setting of card...
Cardiovascular diseases (CVDs) are diseases that affect the heart and blood vessels and to date, the...
Background -Cardiovascular diseases remain the predominant cause of death worldwide, with the preval...
BACKGROUND: Cardiovascular diseases remain the predominant cause of death worldwide, with the preval...
Background-—MicroRNAs (miRNAs) play a key role in the development of heart failure, and recent studi...
Heart failure is preceded by ventricular remodeling, changes in left ventricular mass, and myocardia...
Pathological growth of cardiomyocytes (hypertrophy) is a major determinant for the development of he...
miR-146a is a microRNA whose transcript levels are induced in the heart upon activation of NF-κB, a ...
MicroRNA (miRNA) is an endogenous non-coding RNA species that either inhibits RNA translation or pro...
miR-146a is a microRNA whose transcript levels are induced in the heart upon activation of NF-κB, a ...
<div><p>Cardiac hypertrophy is an adaptive enlargement of the myocardium in response to overload pre...
Rationale: Abnormal SUMOylation has emerged as a characteristic of heart failure (HF) pathology. Pre...
Causes and treatments for heart failure (HF) have been investigated for over a century culminating i...
The H19 lncRNA, a highly abundant and conserved imprinted gene, has been implicated in many essentia...
Cardiac hypertrophy is a frequent pathological reaction to hypertension, pulmonary hypertension, and...
Expression of microRNA-652 (miR-652) increases in the diseased heart, decreases in a setting of card...
Cardiovascular diseases (CVDs) are diseases that affect the heart and blood vessels and to date, the...
Background -Cardiovascular diseases remain the predominant cause of death worldwide, with the preval...
BACKGROUND: Cardiovascular diseases remain the predominant cause of death worldwide, with the preval...
Background-—MicroRNAs (miRNAs) play a key role in the development of heart failure, and recent studi...
Heart failure is preceded by ventricular remodeling, changes in left ventricular mass, and myocardia...
Pathological growth of cardiomyocytes (hypertrophy) is a major determinant for the development of he...
miR-146a is a microRNA whose transcript levels are induced in the heart upon activation of NF-κB, a ...
MicroRNA (miRNA) is an endogenous non-coding RNA species that either inhibits RNA translation or pro...
miR-146a is a microRNA whose transcript levels are induced in the heart upon activation of NF-κB, a ...
<div><p>Cardiac hypertrophy is an adaptive enlargement of the myocardium in response to overload pre...
Rationale: Abnormal SUMOylation has emerged as a characteristic of heart failure (HF) pathology. Pre...
Causes and treatments for heart failure (HF) have been investigated for over a century culminating i...
The H19 lncRNA, a highly abundant and conserved imprinted gene, has been implicated in many essentia...
Cardiac hypertrophy is a frequent pathological reaction to hypertension, pulmonary hypertension, and...
Expression of microRNA-652 (miR-652) increases in the diseased heart, decreases in a setting of card...
Cardiovascular diseases (CVDs) are diseases that affect the heart and blood vessels and to date, the...